Immunome, Inc.
USD21.04
+1.08 (+5.41%)
CEO
Clay Siegall
IPO Date
2020-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$20.15
Prev. Close
$19.96
Day Low
$19.65
Day High
$21.10
52W Low
$7.96
52W High
$27.65
Market Cap
$2.01B
Volume
1.57M
| 60,000 |
| $18.23 |
| 17 Jun 2026 | Rosett Max | Chief Financial Officer | M-Exempt | Disposed | 60,000 | $1.05 |
| 12 Jun 2026 | SWAIN SANDRA M | director | A-Award | Acquired | 9,897 | $18.16 |
| 12 Jun 2026 | WAGENHEIM PHILIP | director | A-Award | Acquired | 9,897 | $18.16 |
| 12 Jun 2026 | BIENAIME JEAN JACQUES | director | A-Award | Acquired | 9,897 | $18.16 |
| 12 Jun 2026 | Boylan James P | director | A-Award | Acquired | 9,897 | $18.16 |
| 12 Jun 2026 | Barchas Isaac | director | A-Award | Acquired | 9,897 | $18.16 |
| 12 Jun 2026 | SCHAFER CAROL | director | A-Award | Acquired | 9,897 | $18.16 |
| 9 Jun 2026 | BIENAIME JEAN JACQUES | director | S-Sale | Disposed | 500 | $19.44 |